Walgreens Boots Alliance Inc (NASDAQ:WBA) has been downgraded to Hold in a report by Zacks Investment Research earlier today.
- Updated: October 6, 2016
Zacks Investment Research has downgraded Walgreens Boots Alliance Inc (NASDAQ:WBA) to Hold in a statement released on 10/6/2016.
On 10/03/2016, Zacks Investment Research released a statement for Walgreens Boots Alliance Inc (NASDAQ:WBA) bumped up the target price from $0.00 to $90.00 that suggested an upside of 0.12%.
Boasting a price of $79.74, Walgreens Boots Alliance Inc (NASDAQ:WBA) traded -0.26% lower on the day. With the last stock price close down -1.12% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Walgreens Boots Alliance Inc has recorded a 50-day average of $81.45 and a two hundred day average of $81.21. Volume of trade was down over the average, with 2,822,350 shares of WBA changing hands under the typical 4,383,730
With a total market value of $0, Walgreens Boots Alliance Inc has price-earnings ratio of 27.75 with a one year low of $71.50 and a one year high of $95.74 .
A total of 22 equity analysts have released a ratings update on WBA. Six equity analysts rating the company a strong buy, ten equity analysts rating the company a buy, ten equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $93.59.
Brief Synopsis About Walgreens Boots Alliance Inc (NASDAQ:WBA)
Walgreens Boots Alliance, Inc. is a holding company. The Company is a pharmacy-led health and wellbeing company. The Company operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores and convenient care clinics, in addition to providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.